Ontology highlight
ABSTRACT: Importance
Cast nephropathy is the main cause of acute kidney injury in multiple myeloma and persistent reduction in kidney function strongly affects prognosis. Strategies to rapidly remove nephrotoxic serum-free light chains combined with novel antimyeloma agents have not been evaluated prospectively.Objective
To compare the hemodialysis independence rate among patients newly diagnosed with myeloma cast nephropathy treated with hemodialysis using a high-cutoff dialyzer (with very large membrane pores and high permeability to immunoglobulin light chains) or a conventional high-flux dialyzer (with small pores and lower permeability).Design, setting, and participants
Randomized clinical trial involving 98 patients with biopsy-proven myeloma cast nephropathy requiring
SUBMITTER: Bridoux F
PROVIDER: S-EPMC5820717 | biostudies-literature | 2017 Dec
REPOSITORIES: biostudies-literature